0

Deep Brain Stimulation Market Share Revenue and Growth Rate to Increase During Forecast Year 2020-2030

Region:Global

Author(s):

Product Code:FG822

Download Sample Report download
Buy the Full ReportStarting from $5000
Published on

July 2021

Total pages

172

Table of Content

Download Sample Report download
Buy the Full ReportStarting from $5000

About the Report

About the Report

Market Overview

Deep brain stimulation is a surgery that involves implanting a device that transmits a signal to the parts of the brain that control movement. DBS helps to alleviate the symptoms of stiffness, sluggishness, and walking difficulties caused by neurological illnesses such dystonia, Parkinson's disease, and essential tremor. Patients who have not responded to medications for at least five years might consider this treatment. Furthermore, the FDA has authorized this medication for individuals who are unable to undergo epilepsy surgery, which involves separating or removing the region of the brain that causes seizures. As a result, the increased frequency of neurological diseases such as Alzheimer's and Parkinson's disease is a primary driver of market expansion.

Deep Brain Stimulation Market: Key Players

  • Abbott (St. Jude Medical)

Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis

  • Medtronic
  • Boston Scientific Corporation
  • Aleva Neurotherapeutics S.A.
  • Nexstim
  • LivaNova PLC
  • Neuropace Inc.
  • Renishaw PLC
  • Beijing PINS Medical Co. Ltd
  • Fisher Wallace

 

Growth Factor

Rapidly aging population

According to the Globe Ageing 2019 study, there were around 703 million people aged 65 and up in the world in 2019. In 2050, this population is expected to increase to 1.5 billion. Furthermore, by 2050, one in every six individuals on the planet will be beyond the age of 65, up from one in every eleven in 2019. The older population is expected to grow, and this group is more susceptible to neurological problems, which will drive the market in the near future.

Segmentation

  • By Stimulation Type
    • Subthalamic DBS
    • Globus Pallidus DBS
    • Thalamic DBS
    • Pedunculopontine Nucleus DBS
  • By Product
    • Single Channel Deep Brain Stimulator
    • Dual Channel Deep Brain Stimulator
  • By Application
    • Parkinson's Disease (PD)
    • Epilepsy
    • Dystonia
    • Obsessive Compulsive Disorder (OCD)
    • Others
  • By End-User
    • Hospitals
    • Ambulatory Surgical Centers
    • Neurological Centers
    • Others
  • Deep Brain Stimulation Market Dynamics
  • Deep Brain Stimulation Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies Involved in the Market
  • Value Chain of the Market
  • Market Drivers and Restraints

 

Recent News Related to Market

  1. In February 2019, Medtronic announced the availability of Deep Brain Simulation (DBS) in the United States for medically resistant epilepsy. Such a unique offering will help the firm expand its consumer base and increase income.

 

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

  • COVID-19 pre and post business impact analysis
  • Detailed overview of the parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • What is the Deep Brain Stimulation Market growth?
  • Which segment accounted for the largest Deep Brain Stimulation Market share?
  • Who are the key players in the Deep Brain Stimulation Market?
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

 

Note: Although care has been taken to maintain the highest levels of accuracy in Fatpos Global’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Products

Table of Contents

Table of Contents

Contents          

  1. Executive Summary
  2. Global Deep Brain Stimulation Market
    1. Product Overview
    2. Market Definition
    3. Segmentation
    4. Assumptions and Acronyms
  3. Research Methodology
    1. Research Objectives
    2. Primary Research
    3. Secondary Research
    4. Forecast Model
    5. Market Size Estimation
  4. Average Pricing Analysis
  5. Macro-Economic Indicators
  6. Market Dynamics
    1. Growth Drivers
    2. Restraints
    3. Opportunity
    4. Trends
  7. Correlation & Regression Analysis
    1. Correlation Matrix
    2. Regression Matrix
  8. Recent Development, Policies & Regulatory Landscape
  9. Risk Analysis
    1. Demand Risk Analysis
    2. Supply Risk Analysis
  10. Global Deep Brain Stimulation Market Analysis
    1. Porters Five Forces
      1. Threat of New Entrants
      2. Bargaining Power of Suppliers
      3. Threat of Substitutes
      4. Rivalry
    2. PEST Analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
  11. Global Deep Brain Stimulation Market
    1. Market Size & forecast, 2020A-2030F
      1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12. Global Deep Brain Stimulation Market: Market Segmentation
    1. By Regions
      1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. Europe: (Germany, UK, France, Italy, Spain, Russia and Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      3. Asia-Pacific: (China, India, Japan, South Korea, Australia, Thailand, Malaysia and Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      4. Latin America: (Brazil, Mexico, Argentina, Colombia, Chile and Venezuela), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      5. MEA: (South Africa, Saudi Arabia, UAE, Turkey and Iran), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
    2. By Stimulation Type: Market Share (2020-2030F)
      1. Subthalamic DBS, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. Globus Pallidus DBS, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      3. Thalamic DBS, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      4. Pedunculopontine Nucleus DBS, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
    3. By Product: Market Share (2020-2030F)
      1. Single Channel Deep Brain Stimulator, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. Dual Channel Deep Brain Stimulator, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
    4. By Application: Market Share (2020-2030F)
      1. Parkinson's Disease (PD), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. Epilepsy, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      3. Dystonia, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      4. Obsessive Compulsive Disorder (OCD), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      5. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
    5. By End-User: Market Share (2020-2030F)
      1. Hospitals, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. Ambulatory Surgical Centers, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      3. Neurological Centers, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      4. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F

Company Profile

  1. Abbott Laboratories
    1. Company Overview
    2. Company Total Revenue (Financials)
    3. Market Potential
    4. Global Presence
    5. Key Performance Indicators
    6. SWOT Analysis
    7. Product Launch
  2. Medtronic
  3. Boston Scientific Corporation
  4. Aleva Neurotherapeutics S.A.
  5. Nexstim
  6. LivaNova PLC
  7. Neuropace Inc.
  8. Renishaw PLC
  9. Beijing PINS Medical Co. Ltd
  10. Fisher Wallace

Consultant Recommendation

**The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.

You can also purchase parts of this report.
Do you want to check out a section wise price list?
Get Price Break-up

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022